Overview: Hepatitis B Surface Antibody TestIntroduction: The Hepatitis B Surface Antibody Test measures antibodies to hepatitis B surface antigen to confirm immunity or vaccine response, preventing infection. Aligned with 2023 AASLD guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding vaccination decisions, travel planning, and improving outcomes in serology for patients with suspected hepatitis B exposure or vaccination.
Other Names: Anti-HBs Assay, Hepatitis B Immunity Test.
FDA Status: FDA-cleared diagnostic test, meeting serology standards for diagnostic accuracy.
Historical Milestone: Hepatitis B antibody testing began in the 1970s with vaccine development. Immunoassays improved in the 1980s, enhancing immunity detection.
Purpose: Confirms hepatitis B immunity or vaccine response, guides vaccination, and monitors anti-HBs in patients to prevent infection.
Test Parameters: 1. Hepatitis B Surface Antibody
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report vaccination history, hepatitis B exposure, or travel to endemic areas.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document vaccination status, history of hepatitis B, or travel to endemic areas. Include current medications and recent infections.
Consent: Written consent required, detailing the tests purpose, immunity implications, and potential need for vaccination.
Procedural Considerations: Uses an immunoassay to detect anti-HBs antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper sample handling or recent vaccination can affect results. Early post-vaccination testing may yield false negatives.
Clinical Significance: Positive anti-HBs indicates immunity from vaccination or past infection, guiding travel or vaccination decisions. Negative results suggest susceptibility.
Specialist Consultation: Consult an infectious disease specialist or hepatologist for result interpretation and vaccination planning.
Additional Supporting Tests: HBsAg, anti-HBc, or HBV DNA to confirm hepatitis B status.
Test Limitations: Early post-vaccination testing may miss antibodies. Clinical correlation is needed.
References: AASLD Hepatitis B Guidelines, 2023; Hepatology, Lok AS, 2022.
